Image

REVEAL Biomarkers of Engraftment After Alternative Donor HSCT

Study on biomarkers to improve alternative donor stem cell transplant outcomes.

Recruiting
4-80 years
All
Phase 1

The study aims to find new tests to check if transplanted bone marrow cells are growing well after Hematopoietic Stem Cell Transplantation (HSCT). Bone marrow is a spongy tissue inside bones that makes blood cells. HSCT is a procedure where unhealthy bone marrow is replaced with healthy cells. To do this, doctors will use a special imaging test called FLT (fluorothymidine) imaging and take blood samples. They want to find out if these tests can show when bone marrow is not growing as expected, a problem called nonengraftment, or if it's just growing slowly, called delayed engraftment. The study will last for 7 years, take place in four centers, and involve up to 56 patients. Participants will have imaging and blood tests several times within the first month after their transplant and will stay in the study for one year. This is a pilot study, meaning it's a small, early-stage study to see if the tests work.

  • Study duration: 1 year for each participant, but the full study lasts 7 years.
  • FLT imaging is done before and after HSCT to check bone marrow growth.
  • Participants need to be able to undergo imaging without sedation and be 4-80 years old.
Study details
    Primary Graft Failure

NCT03541889

University of Oklahoma

1 March 2025

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.